Engineered Bacterial Membranes as Next‐Generation Platforms for Cancer Immunotherapy
Hafiza Aasia Malik, Urooj Yousaf Virk, Mohamed Salah Attia, Jenny Wilson, Ming Wei · 2026
Read Engineered Bacterial Membranes as Next‐Generation Platforms for Cancer Immunotherapy by Hafiza Aasia Malik, Urooj Yousaf Virk, Mohamed Salah Attia, Jenny Wilson, Ming Wei (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13410410.txt.
Description
Hafiza Aasia Malik and colleagues review in 2026 how bacterial membranes are being reshaped into cancer vaccine platforms. A bacterium's outer skin naturally alarms the immune system, which makes it a strong carrier. Engineers can also fix tumor markers onto that skin so the body learns both targets at once.
Forms covered include tiny shed vesicles, emptied bacterial shells, membrane pieces, and blends fused with tumor membranes. Tests in mice with melanoma, lung, breast, and brain tumors showed hotter immune attack inside tumors and help alongside other therapies. New tools, from gene editing to computer-guided antigen choice, speed design. Safety fixes such as softening toxic lipid parts remain central before human use.
Catalog record
| CREATOR | Hafiza Aasia Malik, Urooj Yousaf Virk, Mohamed Salah Attia, Jenny Wilson, Ming Wei |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 65 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |